Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

3 years ago 324

Moderna shares plunged 12.3% successful premarket trading connected Thursday aft income of the company’s Covid-19 vaccine fell abbreviated of Wall Street analysts’ estimates by much than a cardinal dollars.

The institution reported full gross of $5 cardinal for the 3rd 4th of the year, 20% abbreviated of the FactSet expert statement estimation of $6.2 billion. Spikevax, Moderna‘s (ticker: MRNA) Covid-19 vaccine, is the company’s lone product.

The...

Read Entire Article

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

Related

How Can We Skyrocket Our Website Traffic with Guest Posts

TSMC Profit Beats Estimates Thanks to Prolonged Chip Crunch

Top Pharmaceutical Stocks for Q1 2022

Warren Buffett says these are the best stocks to own when in...

Trending

Popular

Akamai adds new capabilities and tools for developers

Muḥammad ibn Mūsā al-Khwārizmī

CNBC’s Cramer confirms he dumped almost all of his Bitcoins

Non-IT pros will build the bulk of tech products and service...

Court Grants Ripple’s Request for Data from 16 Crypto Exchan...